The Prevalence of Eosinophilic Esophagitis with Use of SQ HDM SLIT-tablet
Rationale The SQ house dust mite (HDM) SLIT-tablet is approved in North America for treatment of HDM allergic rhinitis with/without conjunctivitis in adults (ODACTRATM, 12 SQ-HDM, ALK, Denmark). Conclusions The background prevalence of EOE is 57/100,000 persons in the US. [...]the prevalence of EoE...
Gespeichert in:
Veröffentlicht in: | Journal of allergy and clinical immunology 2018-02, Vol.141 (2), p.AB173-AB173 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Rationale The SQ house dust mite (HDM) SLIT-tablet is approved in North America for treatment of HDM allergic rhinitis with/without conjunctivitis in adults (ODACTRATM, 12 SQ-HDM, ALK, Denmark). Conclusions The background prevalence of EOE is 57/100,000 persons in the US. [...]the prevalence of EoE with SQ HDM SLIT-tablet does not support a potential risk related to treatment at this point in time. |
---|---|
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2017.12.552 |